Target intelligence / Profile preview

RNASEH2B antisense RNA 1 (RNASEH2B-AS1)

Target
RNASEH2B-AS1
Molecular classification
Other (long non-coding RNA, IncRNA)
01

Overview

RNASEH2B antisense RNA 1 (RNASEH2B-AS1) is a long non-coding RNA (IncRNA) transcribed antisense to the *RNASEH2B* coding gene. There is limited functional information in the current biomedical literature regarding RNASEH2B-AS1. It does **not encode a protein**, nor is it known to act as a receptor, enzyme, transporter, or other classical drug target. No confirmed molecular or therapeutic roles have been established for RNASEH2B-AS1, and there is no evidence it is directly targeted by any approved drugs or is used as a biomarker in current clinical practice. Most scientific resources and disease-centric reviews focus on the protein-coding gene *RNASEH2B*, which is part of the *RNase H2* enzyme complex, not the antisense IncRNA RNASEH2B-AS1. NOTES: - The main search results focus on *RNASEH2B* (the gene/protein), not *RNASEH2B-AS1*, and do **not provide information supporting RNASEH2B-AS1 as a drug target, biomarker, or well-studied regulatory RNA**[1][3][5][6]. - There is no evidence RNASEH2B-AS1 is misnamed or a receptor/target; rather, it is likely a poorly characterized IncRNA. - If you intended the protein-coding gene or complex (RNASEH2B/RNase H2) instead, review that specific entity (see above-cited search results for RNASEH2B). For RNASEH2B-AS1, information is sparse and inconclusive.

Other names
RNASEH2B-AS1RNASEH2B antisense non-coding RNA 1
02

Biological functions

Other (possible regulation of RNASEH2B gene expression, but currently poorly characterized)
03

Disease associations

Other (no established or well-characterized role in human disease)

Beyond the preview

Go deeper on RNASEH2B antisense RNA 1 (RNASEH2B-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNASEH2B antisense RNA 1 (RNASEH2B-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call